How would you approach a postmenopausal patient with HR-,HER2+ breast cancer who has oligometastatic disease, and is s/p complete resection of brain met with no other evidence of systemic disease?  

Received adjuvant HER2 directed therapy 3 years ago. 



Answer from: Medical Oncologist at Academic Institution